OriGene Technologies, Inc. - Medical Equipment - Deals and Alliances Profile

GlobalData
29 Pages - GLDATA50758
$250.00

Summary

OriGene Technologies, Inc. (OriGene) is a life science company that develops, manufactures and sells genome research and diagnostic products. The company’s products include cDNA clones, qPCR reagents, plasmid purification, HuSH shRNA, siRNA, miRNA, transfection reagent, precisionshuttling kits, proteins antibodies, IHC products, assays and human tissues, among others. It provides services such as gene synthesis, custom cloning, custom shRNA, custom protein service, antibody service, assay development and stable cell line development. OriGene provides research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, and protein kinase. The company offers products and services to pharmaceutical and biotechnology companies and academic research institutes. It distributes its products in Asia, Europe and North American countries. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
OriGene Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
OriGene Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
OriGene Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
OriGene Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
OriGene Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
OriGene Technologies, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
Partnerships 12
OriGene Technologies Enters into Licensing Agreement with Diadexus 12
SDIX Enters Into Licensing Agreement With BD Diagnostic 13
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
DuPont Enters Into Co-Development Agreement With OligoCo 16
OriGene Technologies Enters Into Co-Marketing Agreement With Hitachi Software 17
Asset Transactions 18
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 18
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 20
Acquisition 22
OriGene Technologies Acquires BioCheck 22
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 23
OriGene Technologies, Inc. - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Other Significant Developments 28
Jan 07, 2016: OriGene Technologies Awarded Phase II SBIR Contract to Develop High-Affinity, Anti-Peptide Monoclonal Antibodies for SISCAPA Assays 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
OriGene Technologies, Inc., Medical Equipment, Key Facts 1
OriGene Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
OriGene Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
OriGene Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
OriGene Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
OriGene Technologies, Inc., Deals By Market, 2010 to YTD 2016 8
OriGene Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
OriGene Technologies Enters into Licensing Agreement with Diadexus 12
SDIX Enters Into Licensing Agreement With BD Diagnostic 13
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
DuPont Enters Into Co-Development Agreement With OligoCo 16
OriGene Technologies Enters Into Co-Marketing Agreement With Hitachi Software 17
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 18
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 20
OriGene Technologies Acquires BioCheck 22
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 23
OriGene Technologies, Inc., Key Competitors 24
OriGene Technologies, Inc., Key Employees 25
OriGene Technologies, Inc., Other Locations 26
OriGene Technologies, Inc., Subsidiaries 26

List of Figures
OriGene Technologies, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
OriGene Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
OriGene Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
OriGene Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
OriGene Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
OriGene Technologies, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
OriGene Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
OriGene Technologies, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838